157 related articles for article (PubMed ID: 10940827)
1. Tumor anemia and thrombocytosis in patients with vulvar cancer.
Hefler L; Mayerhofer K; Leibman B; Obermair A; Reinthaller A; Kainz C; Tempfer C
Tumour Biol; 2000; 21(5):309-14. PubMed ID: 10940827
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytosis in women with vulvar carcinoma.
Lavie O; Comerci G; Daras V; Bolger BS; Lopes A; Monaghan JM
Gynecol Oncol; 1999 Jan; 72(1):82-6. PubMed ID: 9889035
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of vascular endothelial growth factor in vulvar cancer.
Hefler L; Tempfer C; Obermair A; Frischmuth K; Sliutz G; Reinthaller A; Leodolter S; Kainz C
Clin Cancer Res; 1999 Oct; 5(10):2806-9. PubMed ID: 10537345
[TBL] [Abstract][Full Text] [Related]
4. The impact of thrombocytosis on clinicopathological prognostic factors and survival in patients with vulvar cancer.
Uysal A; Gültekin E; Taner CE; Mun S; Yidirim Y
Ginekol Pol; 2013 Jun; 84(6):450-5. PubMed ID: 24032263
[TBL] [Abstract][Full Text] [Related]
5. Poor prognosis associated with thrombocytosis in patients with gastric cancer.
Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Satomi T
Ann Surg Oncol; 2002 Apr; 9(3):287-91. PubMed ID: 11923136
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy.
Nather A; Mayerhofer K; Grimm C; Hefler L; Leodolter S; Obermair A; Joura EA
Anticancer Res; 2003; 23(3C):2991-4. PubMed ID: 12926151
[TBL] [Abstract][Full Text] [Related]
7. Impact of pretreatment hematologic profile on survival of colorectal cancer patients.
Qiu MZ; Yuan ZY; Luo HY; Ruan DY; Wang ZQ; Wang FH; Li YH; Xu RH
Tumour Biol; 2010 Aug; 31(4):255-60. PubMed ID: 20336401
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer.
Hefler L; Obermair A; Tempfer C; van Houte M; Maenner G; Reinthaller A; Leodolter S; Kainz C
Int J Cancer; 1999 Jun; 84(3):299-303. PubMed ID: 10371350
[TBL] [Abstract][Full Text] [Related]
9. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
[TBL] [Abstract][Full Text] [Related]
10. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
12. Impact of pretreatment thrombocytosis on survival in primary breast cancer.
Taucher S; Salat A; Gnant M; Kwasny W; Mlineritsch B; Menzel RC; Schmid M; Smola MG; Stierer M; Tausch C; Galid A; Steger G; Jakesz R;
Thromb Haemost; 2003 Jun; 89(6):1098-106. PubMed ID: 12783124
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma.
Tamussino KF; Gücer F; Reich O; Moser F; Petru E; Scholz HS
Int J Gynecol Cancer; 2001; 11(3):236-40. PubMed ID: 11437932
[TBL] [Abstract][Full Text] [Related]
15. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Suppiah R; Shaheen PE; Elson P; Misbah SA; Wood L; Motzer RJ; Negrier S; Andresen SW; Bukowski RM
Cancer; 2006 Oct; 107(8):1793-800. PubMed ID: 16983701
[TBL] [Abstract][Full Text] [Related]
17. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
Rodriguez GC; Clarke-Pearson DL; Soper JT; Berchuck A; Synan I; Dodge RK
Obstet Gynecol; 1994 Mar; 83(3):445-8. PubMed ID: 8127540
[TBL] [Abstract][Full Text] [Related]
18. Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients.
Ferrigno D; Buccheri G
Monaldi Arch Chest Dis; 2003; 59(3):193-8. PubMed ID: 15065314
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytosis as a predictor of distant recurrence in patients with rectal cancer.
Cravioto-Villanueva A; Luna-Perez P; Gutierrez-de la Barrera M; Martinez-Gómez H; Maffuz A; Rojas-Garcia P; Perez-Alvarez C; Rodriguez-Ramirez S; Rodriguez-Antezana E; Ramirez-Ramirez L
Arch Med Res; 2012 May; 43(4):305-11. PubMed ID: 22727694
[TBL] [Abstract][Full Text] [Related]
20. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
